Showing results (21-30 of 64) with videos related to

Sort By:
Pageof 7
Life Sciences|November 10, 1998
Human endothelial cells do not exert heparin like accelerating effects on thrombin-antithrombin-complex formationK Ruzicka, J Wojta, O Artemiou, et al.
Journal of Thrombosis and Haemostasis : JTH|August 19, 2014
No impact of endogenous prothrombotic conditions on the risk of central venous line-related thrombotic events in children: results of the KIDCAT study (KIDs with Catheter Associated Thrombosis)K Thom, C Male, C Mannhalter, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 26, 2009
High factor VIII levels independently predict venous thromboembolism in cancer patients: the cancer and thrombosis studyR Vormittag, R Simanek, C Ay, et al.
Journal of Thrombosis and Haemostasis : JTH|December 13, 2006
Low-density lipoprotein receptor-related protein 1 polymorphism 663 C > T affects clotting factor VIII activity and increases the risk of venous thromboembolismR Vormittag, P Bencur, C Ay, et al.
British Journal of Haematology|February 13, 2001
Treatment of coagulation inhibitors with extracorporeal immunoadsorption (Ig-Therasorb)M Jansen, S Schmaldienst, S Banyai, et al.
Thrombosis Research|October 23, 1997
Evaluation of a new screening assay ProC Global for identification of defects in the protein C/protein S anticoagulant pathwayK Ruzicka, S Kapiotis, P Quehenberger, et al.
Journal of Thrombosis and Haemostasis : JTH|July 23, 2003
The risk of recurrent venous thromboembolism among patients with high factor IX levelsA Weltermann, S Eichinger, C Bialonczyk, et al.
Vox Sanguinis|December 1, 2004
Stability of coagulation factors in thawed, solvent/detergent-treated plasma during storage at 4 degrees C for 6 daysC Buchta, M Felfernig, P Höcker, et al.
European Journal of Clinical Investigation|June 4, 2009
Thrombin generation in haemophilia A patients with factor VIII inhibitors after infusion of recombinant factor VIIaS Eichinger, B Lubsczyk, M Kollars, et al.
Journal of Thrombosis and Haemostasis : JTH|June 11, 2005
The presence of IgG antibodies against beta2-glycoprotein I predicts the risk of thrombosis in patients with the lupus anticoagulantC Zoghlami-Rintelen, R Vormittag, T Sailer, et al.
Pageof 7